HomeBLRX • TLV
Follow
BioLine RX Ltd
Previous close
ILA 27.90
Day range
ILA 27.60 - ILA 28.80
Year range
ILA 17.80 - ILA 70.00
Market cap
83.20M USD
Avg Volume
909.30K
P/E ratio
-
Dividend yield
-
Primary exchange
TLV
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 12.36M | 74.58% |
Net income | -16.02M | -134.01% |
Net profit margin | — | — |
Earnings per share | -0.30 | -100.00% |
EBITDA | -12.14M | -75.25% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 25.97M | -54.65% |
Total assets | 52.86M | -35.28% |
Total liabilities | 39.72M | 51.90% |
Total equity | 13.13M | — |
Shares outstanding | 969.92M | — |
Price to book | 27.90 | — |
Return on assets | -55.27% | — |
Return on capital | -101.22% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -16.02M | -134.01% |
Cash from operations | -9.90M | -14.04% |
Cash from investing | 4.10M | 127.43% |
Cash from financing | 3.50M | -84.60% |
Net change in cash | -2.38M | -165.59% |
Free cash flow | -6.88M | -25.70% |
About
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Wikipedia
Founded
2003
Website
Employees
49